Minerva Imaging scholar program student Sarah successfully defended her Master's thesis on heterogeneous responses to radiotherapy and immune checkpoint inhibition across different preclinical tumor models.
Published
Signal category
Research & Knowledge
Quote
“Last Friday, Sarah from our MI scholar program, successfully defended her Master's thesis under the supervision of Jennifer, Senior Scientist, and Noemi, Scientist at Minerva Imaging, and Geert Berx, Professor at Ghent University.”
— Minerva Imaging team
Company
Minerva Imaging
Accelerated & Efficient Drug Development
- Industry
- Biotechnology Research
- Location
- Ølstykke, DK
- Company size
- 196 employees
Minerva Imaging is a scientifically driven CRO and CDMO specialized in targeted radionuclide therapies. The company focusses on the use of advanced models within oncology, cardiovascular diseases and in vivo molecular imaging for translational research and drug development. Minerva Imaging engages with its clients to understand their scientific questions and discuss how its methods and capabilities can provide answers. The facility located in Denmark offers best–in–industry fully integrated radiopharmaceutical research, drug development and manufacturing services.
Founded 2011